Ionis Pharmaceuticals, Inc.
IONS
$43.03
$0.862.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 184.08% | -40.81% | 25.72% | -112.00% | 53.60% |
| Total Depreciation and Amortization | 1.06% | 2.47% | -4.11% | -1.54% | -1.27% |
| Total Amortization of Deferred Charges | 0.24% | -1.91% | -0.24% | 0.42% | 0.24% |
| Total Other Non-Cash Items | 62.28% | -28.97% | 59.29% | -19.25% | 6.74% |
| Change in Net Operating Assets | 30.82% | 32.92% | -625.68% | 91.00% | -106.56% |
| Cash from Operations | 200.37% | -29.82% | -1.00% | 4.08% | 20.05% |
| Capital Expenditure | 2.16% | 50.67% | -181.55% | -45.27% | -38.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -158.88% | 95.32% | 128.25% | -582.99% | -14.78% |
| Cash from Investing | -170.44% | 149.89% | 120.02% | -645.71% | -17.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 4.76% | 99.91% | -92,702.08% | -23.08% | 0.00% |
| Issuance of Common Stock | -42.57% | 422.38% | -99.91% | 19,009.98% | -89.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -43.29% | 104.98% | -108.89% | 19,299.57% | -89.15% |
| Foreign Exchange rate Adjustments | 156.47% | 147.74% | -238.86% | 1,621.74% | 79.82% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 49.73% | 123.90% | -327.83% | 173.98% | -8.97% |